Stereotactic radiotherapy in three weekly fractions for the management of vestibular schwannomas

This study evaluates the rates of tumor control, hearing preservation and cranial nerve toxicity with the use of CyberKnife stereotactic radiotherapy consisting of 2100 cGy to the 80% isodose line delivered in three weekly fractions to treat vestibular schwannomas.

https://ift.tt/2yz2tvJ